The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
LiverTox: A website on drug-induced liver injury
Open accessAbstract
Drug-induced liver injury is one of the more challenging forms of liver disease, both in diagnosis and management. Several hundred drugs, nutritional supplements, and herbal medications have been implicated in causing liver injury. Their clinical presentation can be highly variable and mimic almost any form of liver disease. The literature on drug-induced liver injury is large, but spread among many journals in many different specialties and languages. Excellent textbooks are available, but they are rapidly out-of-date and not always easily accessed. Drug-induced liver injury is also a challenging area of research, in that most cases are unpredictable, idiosyncratic, and rare and thus difficult to study. As a consequence, there have been few advances in the understanding, control, or prevention of drug-induced liver injury in the last 50 years. DILIN, Drug-Induced Liver Injury Network; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases; NLM, National Library of Medicine. As a part of a long-term initiative in promoting basic and clinical research on drug-induced liver injury, the Liver Disease Research Branch of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in collaboration with the National Library of Medicine (NLM) has created the LiverTox website (www.livertox.nih.gov) (Fig. 1). LiverTox is a multilayered, informational, and interactive website with comprehensive and evidence-based information on drug, dietary supplement, and herbal-induced liver injury that is freely accessible to physicians, researchers, and the public. The website is particularly designed for use by physicians and healthcare professionals who might rarely see patients with drug-induced liver injury, including family practitioners, internists, pediatricians, psychiatrists, surgeons, specialists, and subspecialists in all areas of medicine. The website will also be helpful to hepatologists and experts in hepatotoxicity by providing a complete and accurate summary of information about the clinical features of liver injury for each medication, along with a complete and annotated list of references. Finally, LiverTox will be helpful to patients seeking information on liver injury due to drugs. The LiverTox website. LiverTox consists of three major components: (1) an introductory and background section, (2) separate records on the hepatotoxicity of individual drugs, and (3) an interactive section that allows for submission and assessment of cases. The introductory and background section includes an overview and detailed discussion of the problem of drug-induced liver injury: its frequency, major causes, epidemiology, natural history, diagnosis, and management. The section provides a description of the principal clinical and histologic patterns of liver injury (phenotypes), standardized definitions of terms used, and discussion of methods to diagnose and judge severity and causality in drug-induced liver injury. This section includes specific and detailed information about formal causality assessment instruments such as the Roussel Uclaf Causality Assessment Method (RUCAM), the Maria and Victorino Clinical Scale (M&V), the Naranjo Adverse Drug Reaction Probability Scale, and the Drug Induced-Liver Injury Network (DILIN) Causality Process. The website provides printable copies of the actual instruments, discussion of their relative strengths and weaknesses, and detailed instructions on their completion (manual of operations). The bulk of the LiverTox website consists of individual records on ∼650 different medications, dietary supplements, and herbals. The specific agents are searchable using both generic and trade names. The agents discussed include all of the major known causes of drug-induced liver injury as well as the most commonly used medications in the United States (prescription and nonprescription and whether or not they cause liver injury). Limited numbers of the many drugs, herbals, and nutritional supplements available only outside of the United States are discussed in LiverTox based upon whether they have been implicated in cases of hepatotoxicity. Each drug record is a concise summary (200-400 words) about the drug class, mechanism of action, indications, dose-regimens, frequency of use, and common side effects. This introduction is followed by a concise description of the hepatotoxicity associated with the agent, including its frequency, clinical patterns, and course followed by a brief overview of the known or suspected mechanisms of injury from the medication. A final paragraph summarizes the prognosis and outcome of liver injury from the agent and gives a brief discussion of management. This overview is followed by one to four actual case reports taken from the published literature or from the DILIN Network. The drug record also includes chemical information with the drug structure and specific Internet links to the approved product labeling (package insert). Each drug rec
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Andrade, R. J., Lucena, I. M., Kaplowitz, N., García-Muņoz, B., Borraz, Y., Pachkoria, K., García-Cortés, M., Fernández, C. M., Pelaez, G., Rodrigo, L., et al. (2006) · Hepatology · doi:10.1002/hep.21424 · Cited by 309
Cited by
PubChem in 2021: new data content and improved web interfaces
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa971 · Cited by 3,953
Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C., & Tong, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.015 · Cited by 398
Deep Learning for Drug-Induced Liver Injury
Xu, Y., Dai, Z., Chen, F., Gao, S., Pei, J., & Lai, L. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00238 · Cited by 382
CSH guidelines for the diagnosis and treatment of drug-induced liver injury
Drug-induced Liver Injury (DILI) Study Group, Yu, Y.-C., Chinese Society of Hepatology (CSH), Chinese Medical Association (CMA), Mao, Y.-M., Chen, C.-W., Chen, J.-J., Chen, J., Cong, W.-M., Ding, Y., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9793-2 · Cited by 254
Shah, F., Leung, L., Barton, H. A., Will, Y., Rodrigues, A. D., Greene, N., & Aleo, M. D. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv152 · Cited by 148
Metadata
- Authors
- Hoofnagle, J. H., Serrano, J., Knoben, J. E., & Navarro, V. J.
- Venue
- Hepatology
- Published
- 2013-03
- Volume
- 57
- Issue
- 3
- Pages
- 873-874
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2000660841
- Cited by
- 242
- References
- 3
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LiverTox: A website on drug-induced liver injury. https://app.cochat.ai/papers/10.1002/hep.26175
- The paper
- Hoofnagle, J. H., Serrano, J., Knoben, J. E., & Navarro, V. J. (2013). LiverTox: A website on drug-induced liver injury. Hepatology. https://doi.org/10.1002/hep.26175
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.